据报道 在静脉输液时往往由于不慎将微粒异物输入人体而引起静脉炎、肉芽肿、血栓栓塞和肿瘤等多种疾病。所以美、英、日等国对输液成品中微粒数目早已作了严格限制,并且在临床输液装置上普遍规定使用“终端滤器”的措施,使输液中的微粒数目达到规定的标准。尽管我国药典(77年版)对输液成品中的微粒数目前还未 It is reported that many diseases such as phlebitis, granuloma, thromboembolism and cancer are often caused by the inadvertent introduction of foreign particles into the human body during intravenous infusion. Therefore, the United States, Britain, Japan and other countries on the number of particles in the infusion of products has long been strictly limited, and in the clinical infusion device is generally provided for the use of “terminal filter” measures to make the number of particles in the infusion to meet the required standards. Although the Chinese Pharmacopoeia (77 edition) on the number of particles in the infusion of finished products has not yet